Clinical Trial Update: Cabozantinib S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating cabozantinib malate in patients with advanced solid tumors and HIV infection has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Malignant Solid Neoplasm

Drugs mentioned

• Cabozantinib S-Malate (cabozantinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Malignant Solid Neoplasm, HIV Infection | Phase 1 | Status: COMPLETED | Results posted: 2023-01-10